Aleksandra Kostina

Aleksandra Kostina

Auto-generated profile, based on publicly available information

Aleksandra Kostina

Almazov National Medical Research Centre, Saint Petersburg, Russian Federation

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2020 in Science
Verified
Journal Article
Closed access
PDF file
CTChristina V. Theodoris
Christina V. Theodoris
PZPing Zhou
Ping Zhou
LLLei Liu
Lei Liu
Yu ZhangYu Zhang
Yu Zhang
TNTomohiro Nishino
Tomohiro Nishino
DSDeepak Srivastava
Deepak Srivastava
Machine learning for medicine: Small-molecule screens aimed at identifying therapeutic candidates traditionally search for molecules that affect one to several outputs at most, limiting discovery of true disease-modifying drugs. Theodoris et al. developed a machine-learning approach to identify small molecules that broadly correct gene networks dysregulated in a human induced pluripotent stem cell disease model of a common form of heart disease involving the aortic valve. Gene network correction by the most efficacious therapeutic candidate generalized to primary aortic valve cells derived from more than 20 patients with sporadic aortic valve disease and prevented aortic valve disease in vivo in a mouse model. Science , this issue p. eabd0724

1 April 2016 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
AKAleksandra S. Kostina
Aleksandra S. Kostina
VUVladimir Е. Uspensky
Vladimir Е. Uspensky
OIOlga Irtyuga
Olga Irtyuga
EIElena V. Ignatieva
Elena V. Ignatieva
OFOlga Freylikhman
Olga Freylikhman
Anna MalashichevaAnna Malashicheva
Anna Malashicheva

1 January 2018 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
AKA. Kostina
A. Kostina
ASA. Shishkova
A. Shishkova
EIE. Ignatieva
E. Ignatieva
OIOlga Irtyuga
Olga Irtyuga
MBM. Bogdanova
M. Bogdanova
Anna MalashichevaAnna Malashicheva
Anna Malashicheva

14 July 2019 in Expert Opinion on Therapeutic Targets
Verified
Journal Article
Closed access
GAGiorgio Aquila
Giorgio Aquila
AKAleksandra Kostina
Aleksandra Kostina
FSFrancesco Vieceli Dalla Sega
Francesco Vieceli Dalla Sega
ESEugeniy Shlyakhto
Eugeniy Shlyakhto
AKAnna Kostareva
Anna Kostareva
Anna MalashichevaAnna Malashicheva
Anna Malashicheva
Introduction: The Notch pathway is involved in determining cell fate during development and postnatally in continuously renewing tissues, such as the endothelium, the epithelium, and in the stem cells pool. The dysregulation of the Notch pathway is one of the causes of limited response, or resistance, to available cancer treatments and novel therapeutic strategies based on Notch inhibition are being investigated in preclinical and clinical studies in oncology. A large body of evidence now shows that the dysregulation of the Notch pathway is also involved in the pathophysiology of cardiovascular diseases (CVDs). Areas covered: This review discusses the molecular mechanisms involving Notch which underlie heart failure, aortic valve calcification, and aortic aneurysm. Expert opinion: Despite the existence of preventive, pharmacological and surgical interventions approaches, CVDs are the first causes of mortality worldwide. The Notch pathway is becoming increasingly recognized as being involved in heart failure, aortic aneurysm and aortic valve calcification, which are among the most common global causes of mortality due to CVDs. As already shown in cancer, the dissection of the biological processes and molecular mechanisms involving Notch should pave the way for new strategies to prevent and cure these diseases.

20 November 2018 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
MBMaria Bogdanova
Maria Bogdanova
AKAleksandra Kostina
Aleksandra Kostina
KEKatarina Zihlavnikova Enayati
Katarina Zihlavnikova Enayati
AZArsenii Zabirnyk
Arsenii Zabirnyk
Anna MalashichevaAnna Malashicheva
Anna Malashicheva
ARArkady Rutkovskiy
Arkady Rutkovskiy
Background: Aortic valve calcification is an active proliferative process, where interstitial cells of the valve transform into either myofibroblasts or osteoblast-like cells causing valve deformation, thickening of cusps and finally stenosis. This process may be triggered by several factors including inflammation, mechanical stress or interaction of cells with certain components of extracellular matrix. The matrix is different on the two sides of the valve leaflets. We hypothesize that inflammation and mechanical stress stimulate osteogenic differentiation of human aortic valve interstitial cells (VICs) and this may depend on the side of the leaflet. Methods: Interstitial cells isolated from healthy and calcified human aortic valves were cultured on collagen or elastin coated plates with flexible bottoms, simulating the matrix on the aortic and ventricular side of the valve leaflets, respectively. The cells were subjected to 10% stretch at 1 Hz (FlexCell bioreactor) or treated with 0.1 μg/ml lipopolysaccharide, or both during 24 h. Gene expression of myofibroblast- and osteoblast-specific genes was analyzed by qPCR. VICs cultured in presence of osteogenic medium together with lipopolysaccharide, 10% stretch or both for 14 days were stained for calcification using Alizarin Red. Results: Treatment with lipopolysaccharide increased expression of osteogenic gene bone morphogenetic protein 2 (BMP2) (5-fold increase from control; p = 0.02) and decreased expression of mRNA of myofibroblastic markers: α-smooth muscle actin (ACTA2) (50% reduction from control; p = 0.0006) and calponin (CNN1) (80% reduction from control; p = 0.0001) when cells from calcified valves were cultured on collagen, but not on elastin. Mechanical stretch of VICs cultured on collagen augmented the effect of lipopolysaccharide. Expression of periostin (POSTN) was inhibited in cells from calcified donors after treatment with lipopolysaccharide on collagen (70% reduction from control, p = 0.001), but not on elastin. Lipopolysaccharide and stretch both enhanced the pro-calcific effect of osteogenic medium, further increasing the effect when combined for cells cultured on collagen, but not on elastin. Conclusion: Inflammation and mechanical stress trigger expression of osteogenic genes in VICs in a side-specific manner, while inhibiting the myofibroblastic pathway. Stretch and lipopolysaccharide synergistically increase calcification.

19 January 2016 in International Journal of Vascular Medicine
Verified
Journal Article
Open access
PDF file
Anna MalashichevaAnna Malashicheva
Anna Malashicheva
DKDaria Kostina
Daria Kostina
AKAleksandra Kostina
Aleksandra Kostina
OIOlga Irtyuga
Olga Irtyuga
IVIrina V. Voronkina
Irina V. Voronkina
AKAnna Kostareva
Anna Kostareva
Thoracic aortic aneurysm develops as a result of complex series of events that alter the cellular structure and the composition of the extracellular matrix of the aortic wall. The purpose of the present work was to study the cellular functions of endothelial and smooth muscle cells from the patients with aneurysms of the thoracic aorta. We studied endothelial and smooth muscle cells from aneurysms in patients with bicuspid aortic valve and with tricuspid aortic valve. The expression of key markers of endothelial (CD31, vWF, and VE-cadherin) and smooth muscle (SMA, SM22α, calponin, and vimentin) cells as well extracellular matrix and MMP activity was studied as well as and apoptosis and cell proliferation. Expression of functional markers of endothelial and smooth muscle cells was reduced in patient cells. Cellular proliferation, migration, and synthesis of extracellular matrix proteins are attenuated in the cells of the patients. We show for the first time that aortic endothelial cell phenotype is changed in the thoracic aortic aneurysms compared to normal aortic wall. In conclusion both endothelial and smooth muscle cells from aneurysms of the ascending aorta have downregulated specific cellular markers and altered functional properties, such as growth rate, apoptosis induction, and extracellular matrix synthesis. Thoracic aortic aneurysm develops as a result of complex series of events that alter the cellular structure and the composition of the extracellular matrix of the aortic wall. The purpose of the present work was to study the cellular functions of endothelial and smooth muscle cells from the patients with aneurysms of the thoracic aorta. We studied endothelial and smooth muscle cells from aneurysms in patients with bicuspid aortic valve and with tricuspid aortic valve. The expression of key markers of endothelial (CD31, vWF, and VE-cadherin) and smooth muscle (SMA, SM22α, calponin, and vimentin) cells as well extracellular matrix and MMP activity was studied as well as and apoptosis and cell proliferation. Expression of functional markers of endothelial and smooth muscle cells was reduced in patient cells. Cellular proliferation, migration, and synthesis of extracellular matrix proteins are attenuated in the cells of the patients. We show for the first time that aortic endothelial cell phenotype is changed in the thoracic aortic aneurysms compared to normal aortic wall. In conclusion both endothelial and smooth muscle cells from aneurysms of the ascending aorta have downregulated specific cellular markers and altered functional properties, such as growth rate, apoptosis induction, and extracellular matrix synthesis.